Bausch Health Companies (NYSE: BHC) — Company Overview, News & Financial Data
Bausch Health develops and markets a range of pharmaceutical and medical products across various therapeutic areas.
Bausch Health Companies
Bausch Health (NYSE:BHC) is a diverse healthcare company engaged in developing, manufacturing, and marketing a wide range of pharmaceutical, medical device, and over-the-counter products. Its operations span across several therapeutic areas including eye health, gastroenterology, and dermatology, aiming to improve people’s lives with its products. The company is dedicated to advancing its portfolio through innovative treatments and accessible healthcare solutions. Bausch Health's objective encompasses a commitment to enhancing patient care while strategically growing its global presence through research and development, as well as partnerships and acquisitions.
Snapshot
Operations
Products and/or services of Bausch Health Companies
- Lumify (brimonidine tartrate) eye drops provide reduction of redness to help eyes appear whiter and brighter.
- Lotemax (loteprednol etabonate) is a corticosteroid for eye inflammation and pain treatment.
- Xifaxan (rifaximin) is indicated for irritable bowel syndrome with diarrhea and hepatic encephalopathy.
- Duobrii (halobetasol propionate and tazarotene) lotion treats plaque psoriasis in adults.
- Elidel (pimecrolimus) cream is used for the treatment of atopic dermatitis (eczema) to relieve skin inflammation and itching.
Bausch Health Companies executive team
- Thomas J. AppioCEO & Director
- Jean-Jacques CharhonExecutive VP & CFO
- Seana CarsonExecutive VP & General Counsel
- Aimee J. LenarPresident of US Pharma
- Mirza DautbegovicExecutive VP & COO
- Steven H. LeeSenior VP, Controller & Chief Accounting Officer
- Garen SarafianVP & Head of Investor Relations
- Kathleen FitzpatrickExecutive VP and Chief HR & Communications Officer
- Cees HeimanSenior Vice President of Europe & Canada
- Jiny KimSenior Vice President of Solta Medical
Latest news about Bausch Health Companies
Dividend history
Dividends per share paid by Bausch Health Companies, by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2010 | — | — | — | $1.2800 |
| FY2009 | — | — | — | $0.6450 |
| FY2008 | — | — | — | $1.5000 |
| FY2007 | — | — | — | $1.9858 |
| FY2006 | — | — | — | $0.5000 |
Key financials
Reported results for Bausch Health Companies, in USD.
- Market cap
- 3B
- Revenue (TTM)
- 11.1B
- P/E ratio
- —
- EPS (diluted, TTM)
- -2.3
- Dividend yield
- —
- Profit margin
- -7.6%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 10.3B | 2.2B | 157M | |
| 9.6B | 1.5B | -46M | |
| 8.8B | 963M | -592M | |
| 8.1B | 454M | -225M |